about
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens.TCR-like antibody drug conjugates mediate killing of tumor cells with low peptide/HLA targets.Mechanisms of leukemia resistance to antibody dependent cellular cytotoxicity.Therapeutic Antibodies against Intracellular Tumor AntigensComparison of T Cell Activities Mediated by Human TCRs and CARs That Use the Same Recognition Domains.TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies.
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
T cell receptor mimic antibodies for cancer therapy
@ast
T cell receptor mimic antibodies for cancer therapy
@en
T cell receptor mimic antibodies for cancer therapy
@nl
type
label
T cell receptor mimic antibodies for cancer therapy
@ast
T cell receptor mimic antibodies for cancer therapy
@en
T cell receptor mimic antibodies for cancer therapy
@nl
prefLabel
T cell receptor mimic antibodies for cancer therapy
@ast
T cell receptor mimic antibodies for cancer therapy
@en
T cell receptor mimic antibodies for cancer therapy
@nl
P2093
P2860
P1433
P1476
T cell receptor mimic antibodies for cancer therapy
@en
P2093
Aaron Y Chang
Claire Y Oh
David A Scheinberg
Dmitry Pankov
Emily Casey
Leonid Dubrovsky
P2860
P304
P356
10.1080/2162402X.2015.1049803
P407
P577
2015-06-01T00:00:00Z